Target Name: PUSL1
NCBI ID: G126789
Review Report on PUSL1 Target / Biomarker Content of Review Report on PUSL1 Target / Biomarker
PUSL1
Other Name(s): tRNA pseudouridine synthase-like 1 | pseudouridine synthase like 1 | TRNA pseudouridine synthase-like 1 isoform 1 | tRNA pseudouridylate synthase-like 1 | tRNA-uridine isomerase-like 1 | pseudouridylate synthase like 1 | Pseudouridine synthase like 1, transcript variant 1 | PUSL1_HUMAN | TRNA pseudouridine synthase-like 1 (isoform 2) | PUSL1 variant 2 | PUSL1 variant 1 | Pseudouridine synthase like 1, transcript variant 2

PUSL1: A Potential Drug Target and Biomarker

Pseudouridine synthase-like 1 (PUSL1) is a protein that is expressed in various cell types of the human body, including muscle, heart, and brain. PUSL1 is involved in the synthesis of pseudouridine nucleotides, which are precursors to DNA replication and repair. The study of PUSL1 and its potential functions as a drug target or biomarker has become a growing interest in recent years.

PUSL1 is a member of the Pusl family of proteins, which are known to be involved in various cellular processes, including DNA replication, repair, and metabolism. PUSL1 is responsible for the synthesis of pseudouridine nucleotides, which are essential for the repair of damaged DNA. The Pusl family of proteins includes PUSL2, PUSL3, and PUSL4, which are also involved in the synthesis of pseudouridine nucleotides.

PUSL1 is expressed in various tissues and cells of the human body, including muscle, heart, and brain. It is also involved in the regulation of various cellular processes, including cell division, apoptosis, and inflammation. PUSL1 has been shown to play a role in the regulation of cell proliferation and has been linked to the development of various diseases, including cancer.

In addition to its role in cellular processes, PUSL1 has also been shown to be involved in the regulation of DNA replication and repair. PUSL1 has been shown to interact with the protein responsible for DNA replication, called DNA polymerase. This interaction between PUSL1 and DNA polymerase suggests that PUSL1 may be involved in the regulation of DNA replication and repair.

PUSL1 has also been shown to be involved in the regulation of apoptosis, which is the process by which cells die naturally. PUSL1 has been shown to play a role in the regulation of apoptosis and has been linked to the development of various diseases, including neurodegenerative disorders.

In addition to its role in cellular processes, PUSL1 has also been shown to be involved in the regulation of inflammation. PUSL1 has been shown to interact with the protein responsible for inflammation, called nuclear factor kappa B (NF-kappa-B). This interaction between PUSL1 and NF-kappa-B suggests that PUSL1 may be involved in the regulation of inflammation.

PUSL1 has also been shown to be involved in the regulation of cell adhesion. PUSL1 has been shown to interact with the protein responsible for cell adhesion, called cadherin. This interaction between PUSL1 and cadherin suggests that PUSL1 may be involved in the regulation of cell adhesion.

In conclusion, PUSL1 is a protein that is involved in various cellular processes, including DNA replication, repair, apoptosis, inflammation, and cell adhesion. The study of PUSL1 and its potential functions as a drug target or biomarker is an exciting area of research, with potential implications for the treatment of various diseases. Further research is needed to fully understand the role of PUSL1 in cellular processes and its potential as a drug target or biomarker.

Protein Name: Pseudouridine Synthase Like 1

The "PUSL1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PUSL1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

Putative POM121-like protein 1 | Putative uncharacterized protein C12orf63 | PVALB | PVALEF | PVR | PVRIG | PVT1 | PWAR1 | PWAR4 | PWAR5 | PWAR6 | PWARSN | PWP1 | PWP2 | PWRN1 | PWRN2 | PWRN3 | PWWP2A | PWWP2B | PWWP3A | PWWP3B | PXDC1 | PXDN | PXDNL | PXK | PXMP2 | PXMP4 | PXN | PXN-AS1 | PXT1 | PXYLP1 | PYCARD | PYCR1 | PYCR2 | PYCR3 | PYDC1 | PYDC2 | PYDC2-AS1 | PYGB | PYGL | PYGM | PYGO1 | PYGO2 | PYHIN1 | PYM1 | PYROXD1 | PYROXD2 | Pyruvate Dehydrogenase Complex | Pyruvate dehydrogenase kinase | Pyruvate Kinase | PYY | PYY2 | PZP | QARS1 | QDPR | QKI | QPCT | QPCTL | QPRT | QRFP | QRFPR | QRICH1 | QRICH2 | QRSL1 | QSER1 | QSOX1 | QSOX2 | QTRT1 | QTRT2 | Queuine tRNA-ribosyltransferase | R-Spondin | R3HCC1 | R3HCC1L | R3HDM1 | R3HDM2 | R3HDM4 | R3HDML | R3HDML-AS1 | RAB GTPase | RAB10 | RAB11A | RAB11AP2 | RAB11B | RAB11B-AS1 | RAB11FIP1 | RAB11FIP2 | RAB11FIP3 | RAB11FIP4 | RAB11FIP5 | RAB12 | RAB13 | RAB14 | RAB15 | RAB17 | RAB18 | RAB19 | RAB1A | RAB1B | RAB20 | RAB21